The shown PCR fragments were obtained from cDNA generated by RT reaction with total RNA of HEK293 cells. As a control for DNA contamination, no RT enzyme was added in all "-RT" samples. All oligos used for amplification of the genes are listed in Supplementary Table 1 ChIP assays were performed with NE from mock/Bleo-treated (d) and mock/IR-exposed (e) HEK293 cells using anti-RAD51 or -RAD52 Abs and analyzed by qPCRs using specific primers for transcribed and non-transcribed genes. Error bars represent ±SD of the mean calculated from three independent experiments. for RNA-ChIP assays performed with NE from mock/Bleo/GO-treated HEK293 cells, using the indicated Abs. RT-PCRs were carried out for TUBB, HPRT1, POLB, USP5 and HSP90B genes using intron-specific primers. (c) Similarly, HEK293 cells were exposed with mock/IR and subjected to RNA-ChIP assays, using the indicated Abs, and RT-PCRs were performed with +RT and -RT reactions for 4 genes. DNA-ChIP assays with Bleo-treated HEK293 cells using specific Abs against IgG, Ku70, DNA-PK, XRCC4 (d) and IgG, PARP1 and Lig IIIα (e) followed by PCRs using intron-specific primers for TUBB, HPRT1 and POLB. (f), Upper panels, Western blot analysis to estimate the level of PNKP (left) and 53BP1 (right) in cell extracts from HEK293 cells transfected with control or specific target siRNAs. GAPDH was used as a loading control in cell extracts from HEK293 cells transfected with control or specific target siRNAs. GAPDH was used as a loading control in each case. Lower panels, RNA-ChIP using anti-PNKP (left) and -53BP1 (right) Abs in respective control or depleted cells, followed by RT-PCR analysis using intron-specific primers for TUBB and HPRT1. (g) Control minus RT reactions for RNA-ChIP assays performed with NE from mock/Bleo/GO-treated cells, using anti-RAD51 and -RAD52
Abs. RT-PCRs were carried out for TUBB, HPRT1, POLB and HSP90B genes using intronspecific primers. (h) HEK293 cells were exposed to mock/IR and subjected to RNA-ChIP assay, using anti-RAD51 or -RAD52 Abs and RT-PCRs were performed for TUBB, HPRT1, POLB and HSP90B. (i) Bleo-treated HEK293 cells were mock-or RNase H-treated and subjected to DNA-ChIP assays using anti-PNKP or -53BP1 Abs. Real-time qPCRs were performed using intron-specific primers for TUBB and HPRT1. C t values were used to calculate percent input and error bars represent ±SD of the mean. In each RNA-ChIP assay, 1% input was collected before 
